- Home
- OKTA vs PODD Comparison
OKTA vs PODD Comparison
Compare OKTA & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKTA
- PODD
- Stock Information
- Founded
- OKTA 2009
- PODD 2000
- Country
- OKTA United States
- PODD United States
- Employees
- OKTA N/A
- PODD N/A
- Industry
- OKTA Computer Software: Prepackaged Software
- PODD Medical/Dental Instruments
- Sector
- OKTA Technology
- PODD Health Care
- Exchange
- OKTA Nasdaq
- PODD Nasdaq
- Market Cap
- OKTA 16.6B
- PODD 16.5B
- IPO Year
- OKTA 2017
- PODD 2007
- Fundamental
- Price
- OKTA $92.75
- PODD $282.80
- Analyst Decision
- OKTA Buy
- PODD Buy
- Analyst Count
- OKTA 35
- PODD 16
- Target Price
- OKTA $106.26
- PODD $291.81
- AVG Volume (30 Days)
- OKTA 2.3M
- PODD 574.3K
- Earning Date
- OKTA 03-03-2025
- PODD 02-20-2025
- Dividend Yield
- OKTA N/A
- PODD N/A
- EPS Growth
- OKTA N/A
- PODD 96.40
- EPS
- OKTA N/A
- PODD 5.78
- Revenue
- OKTA $2,533,000,000.00
- PODD $2,071,600,000.00
- Revenue This Year
- OKTA $17.06
- PODD $23.56
- Revenue Next Year
- OKTA $7.78
- PODD $18.07
- P/E Ratio
- OKTA N/A
- PODD $48.93
- Revenue Growth
- OKTA 16.84
- PODD 22.07
- 52 Week Low
- OKTA $70.56
- PODD $160.19
- 52 Week High
- OKTA $114.50
- PODD $289.46
- Technical
- Relative Strength Index (RSI)
- OKTA 49.06
- PODD 54.94
- Support Level
- OKTA $95.11
- PODD $270.00
- Resistance Level
- OKTA $98.00
- PODD $288.95
- Average True Range (ATR)
- OKTA 3.12
- PODD 6.83
- MACD
- OKTA -0.73
- PODD -0.31
- Stochastic Oscillator
- OKTA 12.78
- PODD 65.78
About OKTA Okta Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.